Urbanek, A., Dear, A.J. orcid.org/0000-0003-3055-607X, Rhodes, D.P. orcid.org/0009-0001-4653-8039 et al. (14 more authors) (2026) Two functionally distinct amyloid-β intermediates link aggregation pathways to pathology in Alzheimer’s disease. Nature Communications, 17 (1). 11333. ISSN: 2041-1723
Abstract
Neurotoxic intermediates formed during amyloid-β (Aβ) aggregation are thought to drive Alzheimer’s disease, yet their rarity and transient nature have obscured their identity and formation pathways in the human brain. Here, we combine super-resolution microscopy and single-molecule functional imaging with kinetic modelling to classify Aβ intermediates according to their membrane-disrupting activity and connect their damaging effects to the aggregation pathways that generate them. Applying this framework to recombinant Aβ42, an Alzheimer’s knock-in mouse model and human Alzheimer’s brain tissue, we find two functionally distinct intermediate populations present across all systems. They form through separate aggregation routes and differ in their neurotoxicity, abundance and susceptibility to inhibition. Both damage neurons and glia, but only one converts into plaques. Suppressing these intermediates pharmacologically in mice reduces plaque burden, attenuates astrogliosis and improves cognition. Our findings connect model systems with human pathology and identify intermediate formation pathways as actionable therapeutic targets across protein-misfolding disorders.
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © The Author(s) 2026. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/ licenses/by/4.0/. |
| Keywords: | Alzheimer Disease; Animals; Amyloid beta-Peptides; Humans; Brain; Mice; Plaque, Amyloid; Neurons; Disease Models, Animal; Mice, Transgenic; Protein Aggregation, Pathological; Peptide Fragments; Neuroglia; Female |
| Dates: |
|
| Institution: | The University of Sheffield |
| Academic Units: | The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health |
| Funding Information: | Funder Grant number UK RESEARCH AND INNOVATION MR/V023861/1 Engineering and Physical Sciences Research Council 2594676 |
| Date Deposited: | 18 Nov 2026 12:50 |
| Last Modified: | 18 Nov 2026 12:50 |
| Status: | Published |
| Publisher: | Springer Science and Business Media LLC |
| Refereed: | Yes |
| Identification Number: | 10.1038/s41467-026-79028-0 |
| Related URLs: | |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:248121 |
Download
Filename: s41467-026-79028-0.pdf
Licence: CC-BY 4.0

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)